A Phase 1 Single-Dose, Parallel Group, Randomized, Open-Label Study to Determine the Absolute Bioavailability of ASKP1240 After Intravenous and Subcutaneous Administration in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Bleselumab (Primary) ; Bleselumab (Primary)
- Indications Plaque psoriasis; Transplant rejection
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 27 Apr 2012 New trial record